Evommune
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1891 Page Mill Rd, Palo Alto, California...Phone Number
(925) 247-4481Website
www.evommune.comRevenue
$10 MillionStock Symbol
EVMNIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About Evommune
Evommune is a clinical stage biotechnology company focused on developing therapies that address the underlying drivers of chronic inflammatory diseases. The company uses advanced immunology research to create targeted treatments aimed at improving patient outcomes beyond symptom control, with a pipeline designed for conditions where current treatment options remain limited.Explore more
Evommune Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Evommune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Evommune, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Evommune
Click to see if Evommune had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Evommune launches new products
Check out if Evommune is spiking on competitors!
Earning: See what the market has to say on Evommune recently announced quarterly report
Funding: Get notified immidiatlly once Evommune has new funding data
Check if Evommune has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Evommune
Compare insights from companies similar to Evommune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Evommune is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Evommune is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Evommune.
Evommune financials insights
Gather financial insights about Evommune, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$12.5M
2023
Series B
$57.5M
2024
Series C
$115M
Evommune Tech Stack
A closer look at the technologies used by Evommune
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
Evommune News & Media
Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
PALO ALTO, Calif., Nov. 7, 2025 /PRNewswire/ -- Evommune, Inc. ("Evommune"), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced the closing of its initial public offering of 10,781,250 shares of...NYSE Content Advisory: Pre-Market Update + Evommune & Aeromexico Begin Trading
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Ashley Mastronardi delivers the pre-market update on November...Evommune Announces Pricing of its Initial Public Offering
PALO ALTO, Calif., Nov. 5, 2025 /PRNewswire/ -- Evommune, Inc. ("Evommune"), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced the pricing of its initial public offering of 9,375,000 shares of...Evommune nabs $150M in IPO amid federal shutdown
The immune drugmaker is the second biotech, along with MapLight Therapeutics, to recently use a workaround in U.S. securities law to price an offering during the shutdown.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Evommune
Sign Up For FreeTo access detailed company insights
Evommune is a clinical stage biotechnology company focused on developing therapies that address the underlying drivers of chronic inflammatory diseases. The company uses advanced immunology research to create targeted treatments aimed at improving patient outcomes beyond symptom control, with a pipeline designed for conditions where current treatme... Read More
